From Medscape Oncology

San Antonio Breast Cancer Symposium (SABCS) 2016

December 06 - 10, 2016; San Antonio, Texas

December 06 - 10, 2016 San Antonio, Texas

SABCS Top Cancer Doc: I Have HIV -- Stigma Can Be Devastating The name Eric Winer is practically synonymous with breast cancer research and treatment. He told his dramatic life story at this year's San Antonio Breast Cancer Symposium.
Medscape Medical News, December 12, 2016
SABCS Aromatase Inhibitors: Is Cancer Benefit Worth Cardiac Risk? A new study of endothelial dysfunction in breast cancer patients prompts this question, especially in the context of long-term use.
Medscape Medical News, December 9, 2016
SABCS Next Big Thing in ER+ Breast Cancer: For Early-Stage Too? Inhibition of cyclin-dependent kinases 4 and 6 is now an option for the treatment of estrogen receptor-positive metastatic breast cancer. Is this approach going to work in earlier-stage disease?
Medscape Medical News, December 8, 2016

Top News From SABCS 2016: Slideshow Hot topics include ongoing debate on duration of endocrine therapy, the effect of aromatase inhibitors on cardiac function, and a scalp-cooling device that helps prevent chemo-induced hair loss.

Herceptin Affirmed, Anthracyclines Questioned in Major Trial The landmark BIRCG-006 trial that helped establish trastuzumab as a standard for early-stage HER2-positive breast cancer continues to stir debate over which chemotherapy to pair it with.
Medscape Medical News, Dec 17, 2015
Denosumab Boosts Survival, Not Just Bones, in Breast Cancer New results from the ABSCG-18 trial fuel the argument for bone-strengthening cancer therapies.
Medscape Medical News, Dec 10, 2015
AI vs Tamoxifen for DCIS? A Toss-up, Unless... Both anastrozole and tamoxifen were effective at preventing recurrence of breast cancer in postmenopausal women with ductal carcinoma in situ. Age, toxicities should drive choice, say investigators.
Medscape Medical News, Dec 11, 2015

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Oncology Insights

Previous Coverage

Related Resource